Voyager Therapeutics Inc. Revenue 2015–2025
Voyager Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Voyager Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 2.6 M, a 59.94% decrease year-over-year.
- Voyager Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 27.6 M, a 64.73% decrease year-over-year.
- Voyager Therapeutics Inc. annual revenue for 2025 was 40.4 M, a 49.53% decrease from 2024.
- Voyager Therapeutics Inc. annual revenue for 2024 was 80.0 M, a 68.00% decrease from 2023.
- Voyager Therapeutics Inc. annual revenue for 2023 was 250.0 M, a 511.16% increase from 2022.
- Voyager Therapeutics Inc. annual revenue for 2022 was 40.9 M.
Voyager Therapeutics Inc. (VYGR) — Frequently Asked Questions
Voyager Therapeutics Inc. (VYGR) is a publicly traded US company. It has a market capitalization of $202M. In fiscal 2025 it reported revenue of $40M and net income of -$120M. Explore VYGR's stock price, financial statements, earnings history, margins and key ratios below.
What is Voyager Therapeutics Inc.'s market cap?
Voyager Therapeutics Inc. (VYGR) has a market capitalization of $202M.
What is the VYGR stock price?
VYGR trades at $3.44 (+3.77% on the day).
How much revenue does Voyager Therapeutics Inc. make?
Voyager Therapeutics Inc. reported revenue of $40M in fiscal 2025.
Is VYGR profitable?
In fiscal 2025, Voyager Therapeutics Inc. reported net income of -$120M.